OTCMKTS:BSSP

Reve Technologies Stock Forecast, Price & News

$0.0030

+0.00 (+11.11 %)

(As of 06/18/2021 08:10 PM ET)

Add

Compare

Today's Range

$0.00

▼

$0.00

50-Day Range N/A

52-Week Range

$0.00

▼

$0.01

Volume704.34 million shs

Average Volume182.21 million shs

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

30 days | 90 days | 365 days | Advanced Chart

Receive BSSP News and Ratings via Email

Sign-up to receive the latest news and ratings for Reve Technologies and its competitors with MarketBeat's FREE daily newsletter.

About Reve Technologies

Reve Technologies, Inc., a drug development company, provides advanced therapeutics for the treatment of cancer. It offers irreversible pepsin fraction (IPF), a therapeutic platform technology that is used to facilitate a range of applications. The company's solution is also used for the treatment of autoimmune diseases, such as cirrhosis and Hepatitis C. The company was founded in 2010 and is based in San Clemente, California.

Cantech Holding, Inc. Announces Update On Its Corporate Status And Intent To Become OTC Pink Sheet Current
June 14, 2021 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:BSSP
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.cantechpharma.com
Phone714-907-1241
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.00 out of 5 stars

Medical Sector

2083rd out of 2,101 stocks

Biotechnology Industry

87th out of 89 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Reve Technologies.

0.0 Community Rank

Outperform Votes
Reve Technologies has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Reve Technologies has received 1 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Reve Technologies has received 100.00% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Reve Technologies and other stocks. Vote “Outperform” if you believe BSSP will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BSSP will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Reve Technologies does not currently pay a dividend.
Dividend Growth
Reve Technologies does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Reve Technologies insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Reve Technologies (OTCMKTS:BSSP) Frequently Asked Questions

What stocks does MarketBeat like better than Reve Technologies?

Wall Street analysts have given Reve Technologies a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Reve Technologies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Reve Technologies' key executives?

Reve Technologies' management team includes the following people:

Diana Zhabilov, Chairman & Pres

Who are some of Reve Technologies' key competitors?

Some companies that are related to Reve Technologies include (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 138267 (COM.TO) (COM), Abattis Bioceuticals (ATTBF), Abzena (ABZA), Acrux (ACR), Actinogen Medical (ACW), AdAlta (1AD), Admedus (AHZ), Algernon Pharmaceuticals (AGNPF), Almirall (LBTSF), Amarantus BioScience (AMBS) and Amplia Therapeutics (ATX).
View all of BSSP's competitors.

What is Reve Technologies' stock symbol?

Reve Technologies trades on the OTCMKTS under the ticker symbol "BSSP."

How do I buy shares of Reve Technologies?

Shares of BSSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Reve Technologies' stock price today?

One share of BSSP stock can currently be purchased for approximately $0.00.

What is Reve Technologies' official website?

The official website for Reve Technologies is www.cantechpharma.com.

How can I contact Reve Technologies?

The company can be reached via phone at 714-907-1241.

This page was last updated on 6/21/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.